Discontinuation of Protaphane® InnoLet®: Strategies and safety considerations
This fact sheet provides clinicians with information on safety strategies and considerations related to the discontinuation of Protaphane® InnoLet® in Australia.
Accessibility - We aim to provide documents in an accessible format. If you're having problems using a document with your accessibility tools, please contact us for help.
Copyright - Unless stated otherwise, materials provided are covered by a Creative Commons Attribution-Non-Commercial-No Derivatives (BY-NC-ND) 4.0 International License.
Request permission to reproduce material produced by the Commission by completing this form.
For more information
Publication year
2025
Resource type
Fact sheet or brochure